Pergolide use in Parkinson disease is associated with cardiac valve regurgitation. [electronic resource]
Producer: 20050114Description: 301-4 p. digitalISSN:- 1526-632X
- Aged
- Antiparkinson Agents -- adverse effects
- Aortic Valve Insufficiency -- chemically induced
- Cardiomyopathy, Restrictive -- chemically induced
- Cohort Studies
- Disease Progression
- Female
- Heart Valve Diseases -- chemically induced
- Humans
- Male
- Middle Aged
- Mitral Valve Insufficiency -- chemically induced
- Parkinson Disease -- drug therapy
- Pergolide -- adverse effects
- Pericarditis -- chemically induced
- Pulmonary Valve Insufficiency -- chemically induced
- Single-Blind Method
- Tricuspid Valve Insufficiency -- chemically induced
- Ultrasonography
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.